Lidorestat (IDD 676) for the Treatment of Diabetic Neuropathy
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This clinical trial is to determine an effective dosage and to study the safety of an
investigational drug -lidorestat (IDD-676)- which is intended to stop or slow the progression
of diabetic peripheral neuropathy.